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Sequential surprises; Non endemic mycoses revealing immunodeficiency
Editor, Histoplasmosis is an under-recognized disease in India which should be considered in the differential diagnosis of patients with prolonged fever and granulomatous disease on histopathology without response to anti tubercular drugs. [1] A 34 year old male, an auto-rickshaw driver was admitted with high grade fever and cough with mucoid sputum for two months. He denied history of weight loss, high risk behaviour, overseas travel (Central and South America, Africa and Australia), contact with pets or wild animals, had no sick contacts, and had no history of addictions. On examination he had enlarged cervical lymphnodes which were discrete and non tender, high-grade fever and fine inspiratory crepitations in the left infra axillary and infra scapular areas.
Chest X-ray showed left lower lobe consolidation. HIV, hepatitis B and hepatitis C serologies were negative. Blood and sputum cultures were sterile. Sputum for acid fast bacilli was negative. Contrast enhanced computed tomogram of thorax showed left lateral basal segment consolidation [ Figure 1 ]. Gram stain, acid fast bacilli staining and fungal stain of bronchial washings and bronchio alveolar lavage were negative. Fungal, bacterial and mycobacterial culture of bronchial washings and bronchio alveolar lavage yielded no growth. Cervical lymph node biopsy showed suppurative granulomatous lymphadenitis. GeneXpert test for tuberculosis was negative. Work up for other causes of granulomatous lymphadenitis including serology for brucellosis, serum angiotensin converting enzyme level and C and P anti-neutrophil cytoplasmic antibodies were negative. He was started on anti tubercular drugs empirically considering tuberculosis as the likely cause for granulomatous lymphadenitis and left lower lobe consolidation, even though the tests were negative. After six months of anti tubercular drugs he developed two swellings over the scalp.
He had occasional fever, cough and loss of weight during the six months. Repeat physical examination showed two soft, fluctuant and tender scalp swellings (5 × 4 cm and 1 × 2 cm) with bilateral infra axillary and infra scapular fine crepitations. Hemoglobin was 9.8 g/dl total leucocyte count 23,400/mm 3 with 84% neutrophils, platelet count 4, 69,000/mm 3 , erythrocyte sedimentation rate 99 mm in 1 h and c reactive protein was 18 (normal range <6.0 mg/L). Chest X-ray showed bilateral lower lobe consolidation. Ultra sonography of abdomen showed mild hepatosplenomegaly. Repeat contrast enhanced computed tomogram of thorax showed consolidation in right upper, mid, and bilateral lower lobes with multiple mediastinal, subcarinal and paratracheal lymph nodes.
The pus from the scalp abscess was drained and the abscess wall histopathology revealed intracellular oval shaped fungal organisms with narrow-based budding morphologically consistent with histoplasmosis [ Figure 2a and b]. Culture of pus on Sabouraud's dextrose agar showed growth of dimorphic fungus (yeast form at 37°C and mould at 22°C) after 5 weeks. He was diagnosed to have disseminated histoplasmosis. Work up for an underlying immunodeficient state revealed chronic granulomatous disease (dihydrorhodamine tests showed no uptake in neutrophil oxidative burst after phorbol myristate acetate stimulation). The patient was initially treated with liposomal amphotericin B for 14 days at a dose of 3 mg/kg followed by itraconazole 200 mg twice daily. When reviewed after 2 months he was afebrile, had no cough and the scalp swellings disappeared.
Differential diagnosis for a man with granulomatous lymphadenitis and unresolving pneumonia with new onset swellings over the scalp include a variety of infectious and non infectious causes. Differential diagnosis of granulomatous disease are classified into infections, vasculitis, immunological aberration, leucocyte oxidase deficiency, hypersensitivity, chemicals, and neoplasia. Infectious granulomatous lymphadenitis can be classified into suppurative lymphadenitis and nonsuppurative lymphadenitis. Tularemia, cat scratch disease, yersinia and lymphogranuloma venereum results in suppurative lymphadenitis. Non suppurative granulomatous lymphadenitis can be due to mycobacterium tuberculosis, nontuberculous mycobacteria, toxoplasma, syphilis and brucellosis. Fungal infection (Cryptococcus, Histoplasma, Coccidioidomycosis, Pneumocystis) can cause suppurative and non suppurative granulomatous lymphadenitis. [2] Our patient had granulomatous lymphadenitis and left lower lobe consolidation initially and the tests for granulomatous disorders including bacteria, mycobacteria, fungi and other non infectious causes were negative. Though tests for diagnosis of tuberculosis were negative, condiering the high disease burden across the country, patient was empirically started on anti-tuberculosis treatment. When he presented with new manifestations (scalp swellings) and worsening of pneumonia a diagnosis of disseminated histoplasmosis with chronic granulomatous disease was made by appropriate tests. Granulomatous lymphadenitis in our patient may be secondary to either histoplasmosis or chronic granulomatous disease itself.
Diagnosis of histoplasmosis can be made from culture and histopathology. Other methods include antigen detection, polymerase chain reaction assays and antibody tests. [3, 4] Histopathology is the prime investigative modality, as identification of histoplasma organism in the section provides conclusive evidence of the disease. Skin lesions of histoplasmosis include papules and plaques with or without crusts, pustules and nodules to mucosal ulcers and erosions, molluscum contagiosum-like lesions, acneiform eruptions, erythematous papules and keratotic plaques. [5] Among the forms of histoplasmosis reported from India, disseminated histoplasmosis is the rarest. [6] The clinical features of disseminated form of histoplasmosis are fever, malaise, anorexia, and weight loss, hepatosplenomegaly, lymphadenopathy, pallor and petechiae if pancytopenia is present and mucocutaneous lesions. [4] Patients with defective cell-mediated immunity against the organism are likely to manifest symptomatic disease during the period of acute dissemination including patients with AIDS, transplant recipients, hematologic malignancies, and corticosteroids usage. Chronic granulomatous disease is an immunodeficiency syndrome involving the phagocyte, and is characterized by repeated infections with bacterial and fungal pathogens. Infections in such patients are commonly due to staphylococcus aureus, pseudomonas species, nocardia species, and fungi (such as Aspergillus species and Candida albicans). [6] To conclude, in non-endemic areas like India, where clinical suspicion is low the correct diagnosis of disseminated histoplasmosis is difficult. Disseminated fungal infections should prompt the treating physician to look for an underlying immunodeficient state.
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There are no conflicts of interest. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Biofilm formation is a fungal adaptation strategy for survival against environmental pressures. Fungi form biofilms for metabolic cooperation, acquisition of new genetic traits, and increased stress resistance. We are concerned about the increasing fungal infections. The modern medicine has provided fungi with many niche such as catheters, shunts, tubings, implants, contact lenses, dentures, and prosthetic devices. The devices become colonized by the fungi and form biofilms over the abiotic surfaces. Biofilms are the known causes of chronic recalcitrant infections. [1] The term biofilm was introduced by Costerton in 1985. Biofilms by definition are "a microbially derived sessile community characterized by cells that are irreversibly attached to a substratum or to each other, in a matrix of extracellular polymeric substance and exhibit an altered phenotype with respect to growth rate and gene transcription." [2] Formation occurs in a sequential manner: (a) adherence and adsorption, (b) intermediate stage: it is of maximum metabolic activity. Extracellular matrix (ECM) is enhanced which is the nutrient source and protects biofilm community from desiccation, ultraviolet radiations, immune cells and the antimicrobial agents, and (c) maturation stage: a stage of release and dissemination when newer sites are colonized. Biofilm formation is not a classical virulence factor. However, biofilms do lead to increased pathogenicity as the community of cells gets too big to be phagocytozed. The fungi in biofilms are more tolerant to defensins, oxidative stress, and ECM impairs the recognition of fungal surface epitopes by immune cells, leading to immune escape. In a study done on clinical isolates of Candida, there was a direct correlation between clinical outcomes and mortality in high-biofilm formers than low-biofilm formers. [3] Persister cells in biofilms form at least 1% population. These are dormant cells which ensure the survival even after an extensive and long-term course of antifungal therapy, leading to recurrence and relapse. [4] They are highly tolerant to antifungal agents as they do not divide.
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Antifungals also fail to act effectively as there is an environmental gradient (heterogenicity) within biofilms. These biofilms being mushroom-like structure lead to concentration gradient in the form of oxygen, chemical, pH, or nutrient gradient. Different antibiotic concentrations reach different individual cells in different layers of biofilms. This suboptimal concentration acts as a stimulus for further biofilm formation and also leads to the development of drug resistance. Organisms in biofilm community have minimum inhibitory concentration (MIC) as high as 10-1000-fold greater than that for planktonic organisms.
Other mechanisms involved in drug resistance are increased cell density, alteration in drug targets, and upregulation of efflux pumps as the biofilms mature. ECM acts as a physical barrier to the entry of antifungals. There is an increased concentration of substances such as beta-glucans and mannans in ECM which act as "drug sponges" sequestering the azoles, pyrimidines, or polyenes. [5] ECM has extracellular DNA. If DNase is added to the biofilm models, the MIC of antifungals decreases significantly. [6] 
